Dr. Heidenberg on whether HoLEP study data will influence technique
“I don’t think anybody, at least in our Mayo Clinic practices, is ever doing anything other than apical release HoLEPs these days,” says Daniel J. Heidenberg, MD.
“I don’t think anybody, at least in our Mayo Clinic practices, is ever doing anything other than apical release HoLEPs these days,” says Daniel J. Heidenberg, MD.
Study findings are based on a large nationwide study of patients with stage 5 CKD and type 2 diabetes in Taiwan.
“This was a very special moment, delivering the news to this patient that his cancer is now undetectable following the treatment with 2 doses of…
What’s old is new again in San Antonio. A city rich in history and booming with modern attractions, San Antonio invites visitors to be inspired,…
Findings are from a small randomized trial of patients on peritoneal dialysis.
The 2024 AUA Annual Meeting program will offer more education and innovative programming than ever before! Join us in San Antonio.
The international Prostate Forum presents the latest in prostate cancer treatments with a series of challenge discussions and lectures. Learning Objectives: 1. Implement both doublet…
A late phase 3 trial evaluating the agent is underway at several clinics in Europe.
Stephen Williams discusses the evolving role of blue light cystoscopy in detecting non-muscle invasive bladder cancer (NMIBC). The conversation covers its pathophysiology, diagnostic and surveillance…
Experts in Cleveland Clinic’s Department of Urology are committed to excellence in transformative urologic care, research and teaching.
Designed to foster a spirit of competition and Section pride, the AUA Residents Bowl is the not-to-be-missed event of AUA2024! Each of the eight AUA…